ESLAWEstrella Immunopharma, Inc.vs its industry peers
A metric-by-metric comparison of Estrella Immunopharma, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ESLAWThis | $3M#5 | — | — | — | — | — | — | — | — | — | -19.7%#6 | — |
| ZIVO | $5M#1 | — | — | 31.3x#5 | 468.6%#1 | -72.1%#7 | -8498.9%#4 | — | — | — | 0.0%#4 | — |
| PMCB | $4M#2 | — | 0.1x#1 | — | — | -163.4%#9 | — | -70.6%#2 | -56.0%#1 | — | -56.9%#7 | — |
| CELZ | $4M#3 | — | 0.5x#2 | 681.2x#7 | -45.5%#5 | -9.1%#6 | -102380.2%#8 | -69.3%#1 | -66.1%#2 | 3#2 | -79.8%#9 | — |
| LIMNW | $4M#4 | — | 12.5x#5 | — | — | -187.8%#10 | — | -3395.2%#5 | -170.3%#4 | — | -59.9%#8 | — |
| BCAB | — | — | — | — | — | 14.6%#4 | -19768.3%#6 | — | — | — | -94.5%#11 | — |
| CEROW | $3M#6 | — | — | — | — | — | — | — | — | — | 145.3%#2 | 4.9%#1 |
| CRIS | $2M#7 | 0.1x#4 | 0.5x#3 | 0.3x#2 | -13.4%#4 | 82.5%#1 | -60.5%#1 | -161.5%#3 | -87.3%#3 | — | -96.2%#12 | — |
| CLDI | $2M#9 | 0.0x#3 | 0.6x#4 | 43.1x#6 | — | 10.1%#5 | -44977.8%#7 | -635.4%#4 | — | — | -96.9%#13 | — |
| SLXN | $841267#10 | 0.0x#1 | 19.1x#6 | — | — | 27.9%#3 | — | -27072.7%#6 | — | — | -99.5%#14 | — |
| TVGNW | $526132#11 | — | — | — | — | -91.4%#8 | — | — | — | — | 86.2%#3 | — |
| VIVS | $2M#8 | — | — | 17.0x#4 | -9.0%#3 | -456.4%#12 | -8768.7%#5 | — | — | — | -93.3%#10 | — |
| SCLXW | $356706#12 | — | — | 0.0x#1 | -46.5%#6 | -413.8%#11 | -1143.7%#2 | — | — | 4#1 | 382.5%#1 | — |
| ABPWW | $116152#13 | 0.0x#2 | — | 0.6x#3 | 50.0%#2 | 60.0%#2 | -4618.6%#3 | — | — | — | -19.3%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice